When HIV study funding is delayed, first establish exactly what is delayed: a new award, a continuation action, a payment, or a decision affecting an existing award. Those situations are not interchangeable. Ask your institution’s grants office to confirm the status and relevant award terms in writing, then coordinate a study-continuity plan that protects participants and preserves required oversight.
Identify the funding event before changing study operations
Ask the institutional sponsored-research or grants office to determine whether the issue concerns a pending new award, a continuation, a scheduled payment, or another action on an active award. Have staff check the Notice of Award, current NIH notices, and applicable award conditions; contact the NIH program officer and grants management specialist as appropriate. The available NIH guidance does not establish that these different events carry identical rules.
Do not treat a funding delay as an award termination or as permission to let study authorization lapse. If the award status or authorization is unclear, resolve that question with grants staff and the relevant oversight bodies before making operational changes.
Map near-term obligations and costs
The principal investigator (PI) and study leadership should quickly inventory what must happen during the expected funding gap. This is a practical planning exercise, not a universal NIH checklist.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
- Upcoming participant visits, procedures, and commitments already made to participants.
- Safety monitoring activities, adverse-event follow-up, and required reporting timelines.
- Personnel, site, and laboratory costs that support safe conduct of the study.
- Essential laboratory work, sample handling, and coordination with collaborators.
- Study-monitor or data and safety monitoring body activities and any time-sensitive decisions.
Use the inventory to identify which obligations are time-critical and which costs or activities may be affected. Do not promise participants a changed schedule or stop a study activity solely on the assumption that a delayed payment permits it; confirm the operational and award implications with the responsible institutional and study authorities.
#1 Best Overall
Preserve participant protections and study oversight
NIH states: “Once awarded, an institution must continually monitor the studies for adequate human subjects protections.” NIH also says: “NIH-defined clinical trials are required to provide a Data and Safety Monitoring Plan (DSMP) with the application or proposal.” The plan does not disappear because funding is uncertain. Maintain applicable monitoring and reporting routes, and involve the IRB and relevant study monitor in assessing any proposed operational response. NIH: Post Award Human Subject Activities.
NIH guidance says: “Reportable events must be reported promptly.” Continue to follow the applicable reporting policies and timelines, including for adverse events and other reportable events. A funding gap is not, by itself, a reason to defer a report or bypass established escalation channels. NIH: Post Award Human Subject Activities.
Check approval requirements before pausing or changing visits
A schedule adjustment, pause, or other change to study procedures may have consequences for participant safety, the approved protocol, and the award. Bring the proposed change to the PI, IRB, institutional grants staff, and relevant study monitor before implementing it. NIH states: “In general, any change in research procedures in an active award that would result in an increased risk to human participants requires prior NIH approval before implementation.” NIH also identifies changes in scope as a matter that can require prior approval. Confirm the applicable approval route for the specific change; do not assume IRB review alone resolves award approval requirements. NIH: Post Award Human Subject Activities.
Recommended Free Tools
Keep the proposed response within the study’s approved procedures and award terms unless the required approvals are obtained. Changes to procedures, participant populations, scope, or risk profile should be reviewed before implementation, not retrofitted after the fact.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Assess bridge funding and other budget actions through the award terms
There is no universal bridge-funding, rebudgeting, carryover, or schedule-adjustment rule established here. Whether a particular approach is available depends on the award terms and current NIH guidance, as well as the proposed use of funds. Ask the sponsored-research office to confirm the applicable rules with the awarding institute’s program and grants management contacts before relying on a bridge or moving costs.
NIH’s HIV/AIDS funding overview describes opportunities tied to current scientific priorities, and NHLBI describes expedited review for eligible HIV/AIDS-related applications. Expedited application review is not a guarantee of a specific award date and does not itself resolve a delay affecting an existing award. NIH Office of AIDS Research: HIV/AIDS Funding and NHLBI: HIV/AIDS Research FAQ.
Do not assume a historical emergency flexibility, generic extension, or notice applies to your situation. NIH’s policy notice index contains dated, situation-specific notices; grants staff should check current notices alongside the Notice of Award and confirm applicability with the awarding institute. NIH: Policy Notices.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Quick Recap
Best Value
Rank #4
Who to contact
- PI and study leadership: Coordinate the operational review and identify participant-facing and time-sensitive obligations.
- Sponsored-research or grants office: Verify award status, terms, and the rules for proposed funding or budget actions.
- IRB: Review proposed changes that may affect approved procedures or participant protections.
- Data and safety monitoring body or relevant study monitor: Assess safety-monitoring continuity and any study-specific oversight implications.
- NIH program officer and grants management specialist: Seek award-specific clarification through the appropriate institutional channel.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
